Appointment Strengthens Halozyme’s Board as the Company Advances Its Global Drug Delivery Platform
Bench International today announced the appointment of Jim Lang to the Board of Directors of Halozyme Therapeutics, Inc., a commercial-stage biopharmaceutical company focused on advancing innovative drug delivery technologies that improve how medicines are delivered to patients worldwide.
Mr. Lang brings extensive experience scaling life sciences organizations and providing governance oversight for public companies operating in complex, highly regulated environments. He currently serves on the public boards of OptimizeRx Corp. and BioVie Inc. His background includes supporting enterprise growth, guiding strategic partnerships, and advising leadership teams through periods of transformation and expansion across multiple stages of company development. This expertise aligns closely with Halozyme’s objectives as it advances its drug delivery portfolio and global collaborations with leading pharmaceutical partners.
“Jim brings the rare combination of public-company board experience, strategic scale expertise, and deep understanding of complex life sciences ecosystems,” said Denise (DeeDee) DeMan, Founder, Chairman, and Chief Executive Officer of Bench International. “We were honored to partner with Halozyme on this important board appointment and to support the company’s continued evolution as a leader in drug delivery innovation.”
“I want to thank the Bench International team for their exceptional professionalism, hard work, and dedication. Their thorough approach and commitment to excellence resulted in identifying Jim Lang — an outstanding match for the high standards we set,” said Matthew L. Posard, Chairman of Halozyme’s Nominating and Governance Committee and a member of the Board of Directors.
The appointment reflects Halozyme’s continued focus on strong corporate governance and board leadership as the company advances its strategic priorities and global partnerships within the evolving life sciences landscape.
Media Contact:
Emily Daniele
Chief Operating Officer
Bench International
267-222-0763
